Ayumi E Pottenger, Debashish Roy, Selvi Srinivasan, Thomas E J Chavas, Vladmir Vlaskin, Duy-Khiet Ho, Vincent C Livingston, Mahdi Maktabi, Hsiuling Lin, Jing Zhang, Brandon Pybus, Karl Kudyba, Alison Roth, Peter Senter, George Tyson, Hans E Huber, David Wesche, Rosemary Rochford, Paul A Burke, Patrick S Stayton
Approximately 3.3 billion people live with the threat of Plasmodium vivax malaria. Infection can result in liver-localized hypnozoites, which when reactivated cause relapsing malaria. This work demonstrates that an enzyme-cleavable polymeric prodrug of tafenoquine addresses key requirements for a mass administration, eradication campaign: excellent subcutaneous bioavailability, complete parasite control after a single dose, improved therapeutic window compared to the parent oral drug, and low cost of goods sold (COGS) at less than $1...
April 19, 2024: Science Advances